Healthcare Capital Corp. Warrant
HCCCW
HCCCW was delisted on the 7th of March, 2022.
0 hedge funds and large institutions have $0 invested in Healthcare Capital Corp. Warrant in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 55 closing their positions.
100% less funds holding
Funds holding: 55 → 0 (-55)
100% less capital invested
Capital invested by funds: $7.58M → $0 (-$7.58M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 55
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$2.12M |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$760K |
| 3 |
AGC
Angelo Gordon & Co
New York
|
-$491K |
| 4 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$408K |
| 5 |
LA
Linden Advisors
New York
|
-$348K |
HCCCW Hedge Fund Activity: Q1 2022 in Review
0 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Healthcare Capital Corp. Warrant (HCCCW) for Q1 2022, worth a combined $0 — down 100% from $7.58M a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of HCCCW and 0 opened new positions — a net loss of 55 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $2.12M sold.
- 0 institutional investors held Healthcare Capital Corp. Warrant (HCCCW) as of Q1 2022, down from 55 in Q4 2021.
- Funds reported $0 of Healthcare Capital Corp. Warrant stock for Q1 2022, down 100% quarter-over-quarter.
- 0 funds opened new Healthcare Capital Corp. Warrant positions in Q1 2022 and 55 closed out, a net change of -55 holders.
- The largest Healthcare Capital Corp. Warrant seller in Q1 2022 was Radcliffe Capital Management, an estimated $2.12M sold.
Based on aggregated 13F filings for Q1 2022.